Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T44458 | Target Info | |||
Target Name | Cyclin-dependent kinase 9 (CDK9) | ||||
Synonyms | Tat-associated kinase complex catalytic subunit; TAK; Similar to cyclin-dependent kinase 9; Serine/threonine-protein kinase PITALRE; Cyclin-dependent protein kinase Cdk9; Cell division protein kinase 9; Cell division cycle 2-like protein kinase 4; CDC2L4; CDC2-related kinase; C-2K | ||||
Target Type | Clinical trial Target | ||||
Gene Name | CDK9 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acid anhydride hydrolases | [+] 2 Acid anhydride hydrolases | + | |||
Interacting Target Name | Structural maintenance of chromosomes protein 2 (SMC2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | XCAP-E homolog; SMC2L1; SMC-2; SMC protein 2; PRO0324; hCAP-E; Chromosome-associated protein E; CAPE | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Co-fractionation | [2] | |||
Interacting Protein Name | Structural maintenance of chromosomes protein 4 (SMC4) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CAP.C; CAPC; SMC.4; SMC4L1; hCAP.C | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Co-fractionation | [2] | |||
Cell cycle related proteins | [+] 2 Cell cycle related proteins | + | |||
Interacting Protein Name | Cyclin-T1 (CCNT1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CCNT; CYCT1; HIVE1 | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [1] | |||
4 | Affinity Capture-MS | [5] | |||
5 | Affinity Capture-MS | [6] | |||
6 | Affinity Capture-MS | [7] | |||
7 | Affinity Capture-MS | [8] | |||
8 | Affinity Capture-MS | [9] | |||
9 | Affinity Capture-MS | [10] | |||
10 | Affinity Capture-Western | [11] | |||
11 | Affinity Capture-Western | [12] | |||
12 | Affinity Capture-Western | [13] | |||
13 | Affinity Capture-Western | [14] | |||
14 | Affinity Capture-Western | [15] | |||
15 | Affinity Capture-Western | [16] | |||
16 | Affinity Capture-Western | [10] | |||
17 | Affinity Capture-Western | [17] | |||
18 | Affinity Capture-Western | [18] | |||
19 | Affinity Capture-Western | [19] | |||
20 | Affinity Capture-Western | [20] | |||
Interacting Protein Name | Cyclin-T2 (CCNT2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CYCT2 | ||||
Evidence Score (E-score) | 13 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [1] | |||
4 | Affinity Capture-MS | [5] | |||
5 | Affinity Capture-MS | [6] | |||
6 | Affinity Capture-MS | [7] | |||
7 | Affinity Capture-MS | [8] | |||
8 | Affinity Capture-Western | [17] | |||
9 | Co-crystal Structure | [21] | |||
10 | Co-fractionation | [22] | |||
11 | Co-fractionation | [23] | |||
12 | Reconstituted Complex | [17] | |||
13 | Reconstituted Complex | [24] | |||
Cell division cycle proteins | [+] 2 Cell division cycle proteins | + | |||
Interacting Target Name | Hsp90 co-chaperone Cdc37 (CDC37) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | p50Cdc37; Hsp90 co-chaperone Cdc37, N-terminally processed; Hsp90 chaperone protein kinase-targeting subunit; CDC37A | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [1] | |||
4 | Affinity Capture-MS | [6] | |||
5 | Affinity Capture-MS | [9] | |||
Interacting Protein Name | Retinoblastoma-associated protein (RB1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | OSRC; PPP1R130; RB; p105.Rb; pRb; pp110 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [25] | |||
2 | Biochemical Activity | [26] | |||
3 | Biochemical Activity | [27] | |||
4 | Biochemical Activity | [28] | |||
5 | Co-fractionation | [26] | |||
Ester hydrolases | [+] 1 Ester hydrolases | + | |||
Interacting Target Name | DNA mismatch repair protein MSH2 (MSH2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MutS protein homolog 2; Mismatch repair gene Msh2; hMSH2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [9] | |||
Heat shock proteins | [+] 1 Heat shock proteins | + | |||
Interacting Target Name | Heat shock protein 90 alpha (HSP90A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Renal carcinoma antigen NY-REN-38; LPS-associated protein 2; Lipopolysaccharide-associated protein 2; LAP-2; HSPCA; HSPC1; HSP90A; HSP86; HSP 86; Heat shock protein HSP 90-alpha; Heat shock 86 kDa | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [1] | |||
4 | Affinity Capture-MS | [6] | |||
5 | Affinity Capture-MS | [9] | |||
Isomerases | [+] 1 Isomerases | + | |||
Interacting Target Name | FK506-binding protein 5 (FKBP5) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PPIase FKBP5; Peptidyl-prolyl cis-trans isomerase FKBP5; HSP90-binding immunophilin; FKBP54; FKBP-51; FKBP51; FKBP-5; FF1 antigen; Androgen-regulated protein 6; AIG6; 54 kDa progesterone receptor-associated immunophilin; 51 kDa FKBP; 51 kDa FK506-binding protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [29] | |||
2 | Affinity Capture-MS | [30] | |||
Kinases | [+] 2 Kinases | + | |||
Interacting Protein Name | DNA-directed RNA polymerase II subunit RPB1 (POLR2A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | POLR2; POLRA; RPB1; RPBh1; RPO2; RPOL2; RpIILS; hRPB220; hsRPB1 | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [31] | |||
2 | Biochemical Activity | [32] | |||
3 | Biochemical Activity | [33] | |||
4 | Biochemical Activity | [34] | |||
5 | Biochemical Activity | [35] | |||
6 | Biochemical Activity | [36] | |||
7 | Biochemical Activity | [18] | |||
8 | Biochemical Activity | [37] | |||
9 | Biochemical Activity | [38] | |||
10 | Biochemical Activity | [21] | |||
11 | Biochemical Activity | [39] | |||
12 | Biochemical Activity | [40] | |||
13 | Biochemical Activity | [41] | |||
14 | Biochemical Activity | [42] | |||
15 | Biochemical Activity | [43] | |||
16 | Biochemical Activity | [44] | |||
17 | Biochemical Activity | [45] | |||
18 | Biochemical Activity | [46] | |||
19 | Biochemical Activity | [47] | |||
20 | Co-fractionation | [48] | |||
Interacting Protein Name | Casein kinase II subunit beta (CSNK2B) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CK2B; CK2N; CSK2B; G5A | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-Western | [49] | |||
Ligases | [+] 1 Ligases | + | |||
Interacting Protein Name | Methionyl-tRNA synthetase (MARS) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | METRS; MRS; MTRNS; SPG70 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [9] | |||
One-carbon transferases | [+] 1 One-carbon transferases | + | |||
Interacting Protein Name | Bicoid-interacting protein 3 homolog (MEPCE) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BCDIN3 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [1] | |||
4 | Affinity Capture-MS | [5] | |||
5 | Affinity Capture-MS | [6] | |||
6 | Affinity Capture-MS | [7] | |||
7 | Affinity Capture-Western | [13] | |||
Putative transporters | [+] 1 Putative transporters | + | |||
Interacting Protein Name | MICOS complex subunit MIC60 (IMMT) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HMP; MINOS2; P87; P87/89; P89; PIG52 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Co-fractionation | [50] | |||
Transcription regulators | [+] 5 Transcription regulators | + | |||
Interacting Target Name | Hexamethylene bis-acetamide-inducible protein 1 (HEXIM1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein HEXIM1; Menage a quatre 1; MAQ1; Likely ortholog of mouse cardiac lineage protein 1; HIS1 protein; HIS1; Hexamethylene bis-acetamide-inducible protein 1; Estrogen down-regulated gene 1 protein; CLP1; Cardiac lineage protein 1 | ||||
Evidence Score (E-score) | 13 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [6] | |||
2 | Affinity Capture-MS | [1] | |||
3 | Affinity Capture-MS | [7] | |||
4 | Affinity Capture-MS | [10] | |||
5 | Affinity Capture-Western | [18] | |||
6 | Affinity Capture-Western | [12] | |||
7 | Affinity Capture-Western | [13] | |||
8 | Affinity Capture-Western | [15] | |||
9 | Affinity Capture-Western | [16] | |||
10 | Affinity Capture-Western | [10] | |||
11 | Affinity Capture-Western | [38] | |||
12 | Affinity Capture-Western | [51] | |||
13 | Reconstituted Complex | [18] | |||
Interacting Protein Name | AF4/FMR2 family member 1 (AFF1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AF4; MLLT2; PBM1 | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [1] | |||
4 | Affinity Capture-MS | [5] | |||
5 | Affinity Capture-MS | [6] | |||
6 | Affinity Capture-MS | [8] | |||
7 | Affinity Capture-Western | [14] | |||
8 | Affinity Capture-Western | [13] | |||
Interacting Protein Name | AF4/FMR2 family member 4 (AFF4) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AF5Q31; MCEF | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [8] | |||
2 | Affinity Capture-MS | [1] | |||
3 | Affinity Capture-MS | [5] | |||
4 | Affinity Capture-MS | [6] | |||
5 | Affinity Capture-MS | [7] | |||
6 | Affinity Capture-Western | [31] | |||
7 | Affinity Capture-Western | [14] | |||
8 | Affinity Capture-Western | [15] | |||
Interacting Protein Name | Protein HEXIM2 (HEXIM2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [4] | |||
2 | Affinity Capture-MS | [1] | |||
3 | Affinity Capture-MS | [6] | |||
4 | Affinity Capture-MS | [7] | |||
5 | Affinity Capture-Western | [38] | |||
6 | Affinity Capture-Western | [51] | |||
Interacting Target Name | Proto-oncogene c-Myc (MYC) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor p64; Proto-oncogene c-Myc; Myc proto-oncogene protein; C-myc oncogene; C-myc; Class E basic helix-loop-helix protein 39; bHLHe39 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [52] | |||
2 | Reconstituted Complex | [53] | |||
Translocases | [+] 1 Translocases | + | |||
Interacting Target Name | Sodium pump subunit alpha-1 (ATP1A1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Sodium/potassium-transporting ATPase alpha1; Sodium pump 1; Na+/K+ ATPase 1; ATP1A1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [9] | |||
Other proteins | [+] 10 Other proteins | + | |||
Interacting Protein Name | YEATS domain-containing protein 1 (MLLT1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ENL; LTG19; YEATS1 | ||||
Evidence Score (E-score) | 9 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [1] | |||
4 | Affinity Capture-MS | [5] | |||
5 | Affinity Capture-MS | [6] | |||
6 | Affinity Capture-MS | [8] | |||
7 | Affinity Capture-Western | [31] | |||
8 | Affinity Capture-Western | [14] | |||
9 | Affinity Capture-Western | [15] | |||
Interacting Protein Name | La-related protein 7 (LARP7) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ALAZS; PIP7S | ||||
Evidence Score (E-score) | 9 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [1] | |||
4 | Affinity Capture-MS | [5] | |||
5 | Affinity Capture-MS | [6] | |||
6 | Affinity Capture-MS | [7] | |||
7 | Affinity Capture-MS | [10] | |||
8 | Affinity Capture-Western | [13] | |||
9 | Affinity Capture-Western | [10] | |||
Interacting Protein Name | YEATS domain-containing protein 3 (MLLT3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AF9; YEATS3 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [1] | |||
4 | Affinity Capture-MS | [5] | |||
5 | Affinity Capture-MS | [6] | |||
6 | Affinity Capture-MS | [8] | |||
7 | Affinity Capture-Western | [31] | |||
Interacting Protein Name | Transcription elongation factor SPT5 (SUPT5H) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SPT5; SPT5H; Tat.CT1 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Biochemical Activity | [54] | |||
2 | Biochemical Activity | [55] | |||
3 | Biochemical Activity | [39] | |||
4 | Biochemical Activity | [56] | |||
5 | Reconstituted Complex | [39] | |||
Interacting Protein Name | RNA polymerase II elongation factor ELL2 (ELL2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [8] | |||
2 | Affinity Capture-MS | [1] | |||
3 | Affinity Capture-Western | [31] | |||
4 | Affinity Capture-Western | [15] | |||
Interacting Target Name | Bromodomain-containing protein 4 (BRD4) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein HUNK1; HUNK1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-Western | [12] | |||
3 | Affinity Capture-Western | [16] | |||
Interacting Protein Name | RNA polymerase II-associated factor 1 homolog (PAF1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | F23149_1; PD2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [31] | |||
2 | Co-fractionation | [48] | |||
Interacting Protein Name | Ribophorin I (RPN1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | OST1; RBPH1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [9] | |||
Interacting Protein Name | General transcription factor IIF subunit 1 (GTF2F1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BTF4; RAP74; TF2F1; TFIIF | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [40] | |||
2 | Co-fractionation | [57] | |||
Interacting Protein Name | T-complex protein 1 subunit theta (CCT8) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | C21orf112; Cctq; D21S246; PRED71 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-MS | [9] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in -Catenin-Active Cancers. Cell Syst. 2016 Sep 28;3(3):302-316.e4. | ||||
REF 2 | A high-throughput approach for measuring temporal changes in the interactome. Nat Methods. 2012 Sep;9(9):907-9. | ||||
REF 3 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 4 | The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell. 2015 Jul 16;162(2):425-440. | ||||
REF 5 | The protein interaction landscape of the human CMGC kinase group. Cell Rep. 2013 Apr 25;3(4):1306-20. | ||||
REF 6 | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. Nat Methods. 2013 Apr;10(4):307-14. | ||||
REF 7 | Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme. Mol Cell. 2007 Jul 20;27(2):262-74. | ||||
REF 8 | Human mediator subunit MED26 functions as a docking site for transcription elongation factors. Cell. 2011 Jul 8;146(1):92-104. | ||||
REF 9 | A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency. Mol Cell Proteomics. 2010 May;9(5):811-23. | ||||
REF 10 | The La-related protein LARP7 is a component of the 7SK ribonucleoprotein and affects transcription of cellular and viral polymerase II genes. EMBO Rep. 2008 Jun;9(6):569-75. | ||||
REF 11 | The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature. 2001 Nov 15;414(6861):317-22. | ||||
REF 12 | Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell. 2005 Aug 19;19(4):535-45. | ||||
REF 13 | AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation. Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):E15-24. | ||||
REF 14 | A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription. Cancer Cell. 2010 Feb 17;17(2):198-212. | ||||
REF 15 | The ubiquitin ligase Siah1 controls ELL2 stability and formation of super elongation complexes to modulate gene transcription. Mol Cell. 2012 May 11;46(3):325-34. | ||||
REF 16 | Modulation of a P-TEFb functional equilibrium for the global control of cell growth and differentiation. Mol Cell Biol. 2006 Oct;26(19):7068-76. | ||||
REF 17 | Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 1998 Mar 1;12(5):755-62. | ||||
REF 18 | Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. Mol Cell. 2003 Oct;12(4):971-82. | ||||
REF 19 | The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions. J Cell Sci. 2001 Apr;114(Pt 8):1491-503. | ||||
REF 20 | Functional inactivation of Cdk9 through oligomerization chain reaction. Oncogene. 2003 Jul 31;22(31):4882-8. | ||||
REF 21 | The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. EMBO J. 2008 Jul 9;27(13):1907-18. | ||||
REF 22 | Panorama of ancient metazoan macromolecular complexes. Nature. 2015 Sep 17;525(7569):339-44. | ||||
REF 23 | 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature. 2001 Nov 15;414(6861):322-5. | ||||
REF 24 | The CDK9-associated cyclins T1 and T2 exert opposite effects on HIV-1 Tat activity. AIDS. 1999 Aug 20;13(12):1453-9. | ||||
REF 25 | Physical interaction between pRb and cdk9/cyclinT2 complex. Oncogene. 2002 Jun 13;21(26):4158-65. | ||||
REF 26 | The CDC2-related kinase PITALRE is the catalytic subunit of active multimeric protein complexes. Biochem J. 1996 Oct 1;319 ( Pt 1):293-8. | ||||
REF 27 | CDC2-related kinase PITALRE phosphorylates pRb exclusively on serine and is widely expressed in human tissues. J Cell Physiol. 1997 Aug;172(2):265-73. | ||||
REF 28 | PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3834-8. | ||||
REF 29 | A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways. Cell. 2014 Jul 17;158(2):434-448. | ||||
REF 30 | USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51-AKT signaling. EMBO J. 2017 May 15;36(10):1434-1446. | ||||
REF 31 | Human Polymerase-Associated Factor complex (PAFc) connects the Super Elongation Complex (SEC) to RNA polymerase II on chromatin. Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):E636-45. | ||||
REF 32 | The BRCA1 COOH-terminal region acts as an RNA polymerase II carboxyl-terminal domain kinase inhibitor that modulates p21WAF1/CIP1 expression. J Biol Chem. 2006 Jul 28;281(30):21119-30. | ||||
REF 33 | A uniform procedure for the purification of CDK7/CycH/MAT1, CDK8/CycC and CDK9/CycT1. Biol Proced Online. 2004;6:163-172. | ||||
REF 34 | Retroviral cyclin enhances cyclin-dependent kinase-8 activity. J Virol. 2012 May;86(10):5742-51. | ||||
REF 35 | Three cyclin-dependent kinases preferentially phosphorylate different parts of the C-terminal domain of the large subunit of RNA polymerase II. Eur J Biochem. 2004 Mar;271(5):1004-14. | ||||
REF 36 | Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences. J Biol Chem. 2001 Apr 6;276(14):10913-20. | ||||
REF 37 | Phosphorylated positive transcription elongation factor b (P-TEFb) is tagged for inhibition through association with 7SK snRNA. J Biol Chem. 2004 Feb 6;279(6):4153-60. | ||||
REF 38 | Compensatory contributions of HEXIM1 and HEXIM2 in maintaining the balance of active and inactive positive transcription elongation factor b complexes for control of transcription. J Biol Chem. 2005 Apr 22;280(16):16368-76. | ||||
REF 39 | Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II. Nat Struct Mol Biol. 2012 Nov;19(11):1108-15. | ||||
REF 40 | The C-terminal domain phosphatase and transcription elongation activities of FCP1 are regulated by phosphorylation. Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2328-33. | ||||
REF 41 | The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures. Leukemia. 2011 Jan;25(1):135-44. | ||||
REF 42 | TFIID component TAF7 functionally interacts with both TFIIH and P-TEFb. Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5367-72. | ||||
REF 43 | A protein phosphatase from human T cells augments tat transactivation of the human immunodeficiency virus type 1 long-terminal repeat. Virology. 2002 Apr 25;296(1):6-16. | ||||
REF 44 | Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation. Mol Cell Biol. 2002 Jul;22(13):4622-37. | ||||
REF 45 | CDK9 is constitutively expressed throughout the cell cycle, and its steady-state expression is independent of SKP2. Mol Cell Biol. 2003 Aug;23(15):5165-73. | ||||
REF 46 | Phosphorylation by cyclin-dependent kinase-9 controls ubiquitin-conjugating enzyme-2A function. Cell Cycle. 2012 Jun 1;11(11):2122-7. | ||||
REF 47 | A human immunodeficiency virus type 1 Tat-like arginine-rich RNA-binding domain is essential for HEXIM1 to inhibit RNA polymerase II transcription through 7SK snRNA-mediated inactivation of P-TEFb. Mol Cell Biol. 2004 Jun;24(12):5094-105. | ||||
REF 48 | H2B ubiquitylation promotes RNA Pol II processivity via PAF1 and pTEFb. Mol Cell. 2014 Jun 19;54(6):920-931. | ||||
REF 49 | Cdk9 phosphorylates p53 on serine 392 independently of CKII. J Cell Physiol. 2006 Sep;208(3):602-12. | ||||
REF 50 | Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J. 1997 May 15;16(10):2836-50. | ||||
REF 51 | HEXIM2, a HEXIM1-related protein, regulates positive transcription elongation factor b through association with 7SK. J Biol Chem. 2005 Apr 22;280(16):16360-7. | ||||
REF 52 | c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis. Oncogene. 2003 Aug 28;22(36):5707-11. | ||||
REF 53 | c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism. J Biol Chem. 2001 Dec 21;276(51):48562-71. | ||||
REF 54 | Dichotomous but stringent substrate selection by the dual-function Cdk7 complex revealed by chemical genetics. Nat Struct Mol Biol. 2006 Jan;13(1):55-62. | ||||
REF 55 | CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. Mol Cell Biol. 2000 Sep;20(18):6958-69. | ||||
REF 56 | Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor. EMBO J. 2004 Jul 7;23(13):2608-19. | ||||
REF 57 | A census of human soluble protein complexes. Cell. 2012 Aug 31;150(5):1068-81. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.